Risikoadaptierte Früherkennung-Reference-Cited by-同舟云学术

Risikoadaptierte Früherkennung

Published:2014-02-21 Issue:3 Volume:57 Page:307-311
ISSN:1436-9990
Container-title:Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz
language:de
Short-container-title:Bundesgesundheitsbl.

Author:

Rhiem K.,Schmutzler R.K.

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health

Link

http://link.springer.com/content/pdf/10.1007/s00103-013-1910-3.pdf

Reference34 articles.

1. „Krebs in Deutschland 2007/2008“ des Robert Koch-Instituts (Stand 02.07.2012). http://www.rki.de/DE/Content/Gesundheitsmonitoring/Krebsregisterdaten/krebs_node.html

2. Ford D, Easton DF, Stratton M, Narod S et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The breast cancer linkage consortium. Am J Hum Genet 62:676–689

3. Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117–1130

4. Miki Y, Swensen J, Shattuck-Eidens D et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66–71

5. Wooster R, Bignell G, Lancaster J et al (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789–792

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implementation and evaluation of a nurse-led decision-coaching program for healthy breast cancer susceptibility gene (BRCA1/2) mutation carriers: a study protocol for the randomized controlled EDCP-BRCA study;Trials;2020-06-08

2. Entwicklung der Krebsfrüherkennung in Deutschland;Forum;2019-10-31

3. Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working Group;JCO Precision Oncology;2018-11

4. Entwicklung der Krebsfrüherkennung in Deutschland;Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz;2018-10-11

5. Digital breast tomosynthesis plus synthesised images versus standard full-field digital mammography in population-based screening (TOSYMA): protocol of a randomised controlled trial;BMJ Open;2018-05